Latest pharmaceutical industry Stories
REDWOOD CITY, Calif., May 16, 2013 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today announced that Richard King, President and CEO, will present a corporate overview at the UBS Global Healthcare Conference at the Sheraton New York Hotel in New York, NY. The presentation is scheduled for Wednesday, May 22,...
AdhereTech receives $50,000 grand prize in global diabetes innovation challenge funded by Boehringer Ingelheim NEW YORK, May 16, 2013 /PRNewswire/ -- Developers of a pill bottle that wirelessly transmits data, measures medication and sends patient reminders have emerged as grand prize winners in the Healthcare Innovation World Cup, the international diabetes innovation challenge funded by Boehringer Ingelheim and organized by HITLAB. Winning team members Josh Stein, John Langhauser...
Chinese malaria drugs giant, Guilin, launches effort in Africa to enable patients and consumers detect fake malaria drugs using mobile phone technology, goldkeys. Shanghai, China (PRWEB) May 15, 2013 Guilin Pharmaceuticals, the World’s first producer of artesunate prequalified by the World Health Organisation as meeting the global body’s stringent standards for safety, quality and efficacy, has chalked another first. The company, which manages the world’s largest vertically...
TAIPEI, Taiwan, May 16, 2013 /PRNewswire/ -- TaiGen Biotechnology Company, Limited ("TaiGen") today announced that they have submitted New Drug Application (NDA) for the oral formulation of nemonoxacin with the Taiwan Food and Drug Administration (TFDA) and China Food and Drug Administration (CFDA). Approval is expected in the first half of 2014. Nemonoxacin is the first pharmaceutical product to fall under the Cross-Strait Cooperation Agreement on Medicine and Public Health Affairs...
More players are expected to enter the Pain Medication OTC Manufacturing industry over the next five years as patents expire. For this reason, industry research firm IBISWorld has added a report on the Pain Medication OTC Manufacturing in Australia to its growing industry report collection. Melbourne, Australia (PRWEB) May 16, 2013 The Pain Medication OTC Manufacturing industry manufactures pharmaceutical products that focus on pain relief and are available without a doctor's...
JERSEY CITY, N.J., May 15, 2013 /PRNewswire/ -- Aoxing Pharmaceutical Company, Inc. (NYSE MKT: AXN) ("Aoxing Pharma"), a specialty pharmaceutical company focusing on research, development, manufacturing, and distribution of narcotic, pain-management, and addiction treatment pharmaceuticals, today announced its financial and operational results for the three and nine month periods ended March 31, 2013. Complete financial results can be found in the Quarterly Report on Form 10-Q filed...
FARMINGTON, Conn., May 15, 2013 /PRNewswire-iReach/ -- World Pharma Congress is celebrating 12 years of preclinical research with its annual event covering the latest in drug targets, high-throughput screening, lead optimization, ADME and drug safety. Years of effectively covering the latest preclinical strategies and technologies that drive better predictions has culminated in priming this year's event to move further downstream into early formulations and drug delivery. (Photo:...
PITTSBURGH, May 15, 2013 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Zolmitriptan Tablets, 2.5 mg and 5 mg. This product is the generic version of IPR Pharmaceuticals Inc.'s Zomig(® )Tablets and is indicated for the acute treatment of migraine with or without aura in adults. Zolmitriptan...
Edgemont enhances its position as the leading M&A advisor to clinical research site companies NEW YORK, May 15, 2013 /PRNewswire/ -- Edgemont Capital Partners ("Edgemont"), a specialty investment bank focused on the merger and acquisition advisory needs of healthcare companies, has acted as exclusive financial advisor to Vince and Associates Clinical Research ("Vince and Associates") in its sale to Altasciences Group. Vince and Associates manages complex early development clinical...
PENZBERG, Germany, May 15, 2013 /PRNewswire/ -- Researchers from academia throughout Europe are invited to participate In a newly created award, pRED`s Discovery Oncology unit of Roche (SIX: RO, ROG; OTCQX: RHHBY) in Penzberg, Germany invites European researchers to submit abstracts which describe their scientific work in the field of tumor-selective membrane targets for antibody-based cancer therapy. The award aims to honor and support outstanding research in the...
